A detailed history of Cedar Brook Financial Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cedar Brook Financial Partners, LLC holds 1,792 shares of MRK stock, worth $197,442. This represents 1.66% of its overall portfolio holdings.

Number of Shares
1,792
Previous 5,879 69.52%
Holding current value
$197,442
Previous $775,000 71.48%
% of portfolio
1.66%
Previous 0.16%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$123.8 - $132.96 $505,970 - $543,407
-4,087 Reduced 69.52%
1,792 $221,000
Q1 2024

Apr 17, 2024

SELL
$113.24 - $131.95 $7,813 - $9,104
-69 Reduced 1.16%
5,879 $775,000
Q4 2023

Jan 12, 2024

SELL
$100.18 - $109.02 $3,105 - $3,379
-31 Reduced 0.52%
5,948 $648,000
Q3 2023

Oct 17, 2023

SELL
$102.95 - $114.33 $65,888 - $73,171
-640 Reduced 9.67%
5,979 $615,000
Q2 2023

Jul 05, 2023

BUY
$108.61 - $118.38 $4,670 - $5,090
43 Added 0.65%
6,619 $763,000
Q1 2023

Apr 04, 2023

SELL
$102.94 - $114.86 $16,470 - $18,377
-160 Reduced 2.38%
6,576 $699,000
Q4 2022

Feb 01, 2023

BUY
$87.44 - $112.11 $43,107 - $55,270
493 Added 7.9%
6,736 $747,000
Q3 2022

Jan 03, 2023

BUY
$84.53 - $94.96 $56,381 - $63,338
667 Added 11.96%
6,243 $537,000
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $2,087 - $2,366
-25 Reduced 0.45%
5,576 $508,000
Q1 2022

Apr 06, 2022

BUY
$73.51 - $82.4 $52,706 - $59,080
717 Added 14.68%
5,601 $460,000
Q4 2021

Jan 27, 2022

BUY
$72.28 - $90.54 $722 - $905
10 Added 0.21%
4,884 $374,000
Q3 2021

Nov 01, 2021

SELL
$71.68 - $78.83 $14,622 - $16,081
-204 Reduced 4.02%
4,874 $366,000
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $21,655 - $23,953
308 Added 6.46%
5,078 $395,000
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $21,690 - $25,549
-315 Reduced 6.19%
4,770 $368,000
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $6,100 - $6,770
85 Added 1.7%
5,085 $416,000
Q3 2020

Nov 09, 2020

BUY
$73.18 - $82.95 $19,392 - $21,981
265 Added 5.6%
5,000 $395,000
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $30,069 - $34,215
427 Added 9.91%
4,735 $366,000
Q1 2020

May 07, 2020

SELL
$63.36 - $87.82 $31,046 - $43,031
-490 Reduced 10.21%
4,308 $331,000
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $30,023 - $33,877
387 Added 8.77%
4,798 $436,000
Q3 2019

Oct 24, 2019

BUY
$76.08 - $82.93 $20,922 - $22,805
275 Added 6.65%
4,411 $371,000
Q2 2019

Aug 06, 2019

SELL
$69.84 - $81.59 $9,218 - $10,769
-132 Reduced 3.09%
4,136 $347,000
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $17,047 - $19,443
245 Added 6.09%
4,268 $355,000
Q4 2018

Feb 11, 2019

BUY
$65.24 - $75.71 $262,460 - $304,581
4,023 New
4,023 $293,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $279B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cedar Brook Financial Partners, LLC Portfolio

Follow Cedar Brook Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.